Tag: Company News

FILE PHOTO: An artificial heart by French manufacturer Carmat is seen during an interview with Reuters in Velizy, near Paris, January 11, 2021. REUTERS/Christian HartmannPARIS (Reuters) – French artificial heartmaker CARMAT announced on Monday the first commercial implant of its Aeson artificial heart at a hospital in Italy, which the company said paved the way

FILE PHOTO: A sign is pictured outside an Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar(Reuters) -Eli Lilly and Co said on Monday it had a revised agreement with the U.S. government for its COVID-19 antibody drug, bamlanivimab,

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) – Roche’s Evrysdi has won approval from the European Commission as the first and only at-home treatment for spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday. It has

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) -Swiss drugmakers Roche and Novartis each won European approval for drugs on Tuesday in a sign that the rival Basel-based companies are increasingly competing for the same patients. Roche’s Evrysdi,

FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the French company’s headquarters in Rueil-Malmaison near Paris, France, April 22, 2020. REUTERS/Charles PlatiauZURICH (Reuters) – Novartis is laying off 400 people and closing a U.S. gene therapy location that it bought only two years ago to make its $2.1 million per patient treatment

BRUSSELS (Reuters) – AstraZeneca’s new aim to supply 30 million doses of its COVID-19 vaccine to the European Union by the end of March hinges on the bloc’s drug regulator approving supplies from a factory in the Netherlands, an internal document showed.FILE PHOTO: A test tube labelled “vaccine” in front of an AstraZeneca logo in

FILE PHOTO: Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company’s headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd WiegmannZURICH (Reuters) – Idorsia’s insomnia drug was accepted for review by U.S. regulators, the Swiss drugmaker said on Wednesday, as founder Jean-Paul

Slideshow ( 2 images )OTTAWA (Reuters) – Canada is “very optimistic” it can speed up its COVID-19 inoculation program, Prime Minister Justin Trudeau said on Wednesday, a day after Washington moved up its own deadline by two months. Trudeau’s Liberal government, under fire for the slow pace of injections so far, has repeatedly insisted that

U.S. President Joe Biden delivers remarks as he takes part in a Munich Security Conference virtual event from the East Room at the White House in Washington, U.S., February 19, 2021. REUTERS/Kevin LamarquePORTAGE, Mich. (Reuters) – President Joe Biden on Friday said he is confident the United States will exceed his goal of delivering 100

FRANKFURT (Reuters) – Pfizer Inc and BioNTech SE have asked the U.S. health regulator to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially allowing it to be kept in pharmacy freezers. Approval by the Food and Drug Administration (FDA) could send a strong signal to other regulators around the world

ZURICH (Reuters) – Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.Slideshow ( 2 images )Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson